Catalina Research Institute

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)4 trials
• Obesity4 trials
• Depression2 trials
• Type 2 diabetes2 trials
• Alzheimer disease1 trial
• High blood pressure1 trial
• Insomnia1 trial
• Obstructive sleep apnoea1 trial

Phase

• Phase 27 trials
• Phase 35 trials

Status

• Completed8 trials
• Active, not recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Amgen2 trials
• Rivus Pharmaceuticals, Inc.2 trials
• Apnimed1 trial
• Cybin IRL Limited1 trial
• Eli Lilly and Company1 trial
• and 5 more

Running trials

• Recruiting

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  NCT07684235· Phase 3· Amgen· Source

• Recruiting

  A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

  NCT07491458· Phase 2· Rivus Pharmaceuticals, Inc.· Source

  Contact: Michael Gallardo

• Active, not recruiting

  Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858839· Phase 3· Amgen· Source

• Active, not recruiting

  Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

  NCT05979779· Phase 2· Rivus Pharmaceuticals, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

  NCT06564818· Phase 3· Cybin IRL Limited· Source

• Completed

  A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

  NCT06538116· Phase 2· Eli Lilly and Company· Source

• Completed

  Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

  NCT05813275· Phase 3· Apnimed· Source

• Completed

  Safety and Efficacy Study of S-309309 in Obese Adults

  NCT05925114· Phase 2· Shionogi· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source

• Completed

  HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

  NCT05623189· Phase 2· HighTide Therapeutics (Hong Kong) Limited· Source

• Completed

  A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

  NCT04880031· Phase 2· GlaxoSmithKline· Source

• Completed

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

  NCT04533529· Phase 3· Janssen Research & Development, LLC· Source